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Abstract  1 
Introduction: Disturbed muscular architecture, atrophy and fatty infiltration remain 2 
irreversible in chronic rotator cuff tears (RCT) even after repair. Poly (ADP-ribose) 3 
polymerase-1 (PARP-1) has shown to be a key regulator of inflammation, apoptosis, muscle 4 
atrophy, muscle regeneration and adipocyte development. We hypothesized that the absence 5 
of PARP-1 would lead to a reduction in damage to the muscle subsequent to combined 6 
tenotomy and neurectomy in a PARP-1 knock-out mouse model.  7 
Methods:  PARP-1 knock-out (PARP-1 KO group) and wild type C57BL/6 (WT group) mice 8 
were analyzed at different time points (1, 6 and 12 weeks, total n=84). In all mice the 9 
supraspinatus and infraspinatus muscles of the left shoulder were detached and denervated. 10 
Macroscopic analysis, magnetic resonance imaging, gene expression analysis, 11 
immunohistochemistry and histology were used to assess the differences in PARP-1 KO and 12 
WT mice. 13 
Results:  The muscles in the PARP-1 KO group had significantly less retraction, atrophy and 14 
fatty infiltration after 12 weeks than in the WT group. Gene expression of inflammatory, 15 
apoptotic, adipogenic and muscular atrophy genes was significantly decreased in PARP-1 KO 16 
mice in the first 6 weeks. 17 
Discussion: Absence of PARP-1 leads to a reduction in muscular architectural damage, early 18 
inflammation, apoptosis, atrophy and fatty infiltration after combined tenotomy and 19 
neurectomy of the rotator cuff muscle. Although the macroscopic reaction to injury is similar 20 
in the first 6 weeks, the muscles ability to regenerate is much greater in the PARP-1 KO 21 
group leading to a near normalization of the muscle after 12 weeks. 22 
Keywords: rotator cuff tear; PARP-1; ARTD1; supraspinatus muscle; mouse model; 23 
inflammation; muscle atrophy; fatty infiltration 24 
25 
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Introduction 26 
Rotator cuff tears (RCT) cause profound and potentially irreversible structural alterations in 27 
the affected muscle. There is significant migration of inflammatory cells within the first few 28 
days of a tear and the muscle fibers undergo apoptosis 
27; 32
. The infiltrate of inflammatory 29 
cells releases Interleukin1-ß (IL1-ß) and Tumor Necrosis Factor α (TNFα), which incites the 30 
inflammatory cascade 
32
. These factors activate intracellular Nuclear Factor kappa B (NF-κB) 31 
which not only induces apoptosis and muscular atrophy, but also inhibits muscle regeneration 32 
23; 32; 35; 42
. Pro-fibrotic factors from the surrounding extracellular matrix (ECM) 
24
 are released 33 
and activated. These factors are members of the Transforming Growth Factor beta (TGFβ) 34 
superfamily and are key regulators of gene expression in muscle homeostasis 
20
. They lead to 35 
the degradation of the injured muscle fibers and the clearance of cellular debris by M1 36 
macrophages. Once the cellular debris have been evacuated, the monocytes transform into 37 
anti-inflammatory M2reg macrophages to support myogenesis 
1
 with the expression of 38 
myogenic regulatory factors (MRFs) 
45
, which in combination with other endocrine growth 39 
factors instigate the development mature myocytes from precursor cells 
45
. If the tendon 40 
remains torn, unloaded and retracted, the macrophages switch to become pro-fibrotic M2a 41 
macrophages and reprogram myogenic precursor cells into the adipogenic pathway, with 42 
mature adipocytes infiltrating the free inter- and intramyofibrillar spaces 
9
. This phenomenon 43 
is termed fatty infiltration 
2; 27
. Although reloading the dynamic musculotendinous units leads 44 
to partial recovery of atrophy and retraction, fatty infiltration remains irreversible 
5; 18
. The 45 
degree of fatty infiltration in a chronically torn rotator cuff is a negative predictor for a 46 
successful surgical outcome 
46
.  47 
 48 
 49 
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The complex interplay of molecular and cellular mechanisms, which leads to potentially 50 
irreversible structural alterations in skeletal muscle, is well described 
22
.  However, a single 51 
upstream regulator may orchestrate this molecular cascade. The discovery of such a regulator 52 
could potentially provide a future target for therapeutic interventions at the molecular level 53 
that may enhance the recovery of rotator cuff muscles post surgical repair. 54 
 55 
Poly (ADP-ribose) polymerase-1 (PARP-1), also known as ADP-ribosyltransferase (ARTD1), 56 
is a key transcription factor involved in the maintenance of cellular homeostasis 
37
. It activates 57 
NF-κB transcription during the inflammatory response which not only induces apoptosis and 58 
muscular atrophy, but also inhibits muscle regeneration 
14; 42
; it promotes a caspase 59 
independent pathway of apoptosis via the apoptosis inducing factor (AIF) 
15
; it regulates the 60 
expression of peroxisome proliferator-activated receptor gamma (PPARγ), which has a role in 61 
adipogenesis and may induce fatty infiltration of the muscle 
7
 ; it also induces muscular 62 
atrophy and fibrosis whilst depressing regenerative pathways 
17; 40
. Hence, PARP-1 may be 63 
the upstream regulator that orchestrates the molecular and cellular mechanisms that leads to 64 
potentially irreversible structural alterations after RCT. 65 
 66 
We therefore hypothesized that the absence of PARP-1 would lead to a reduction in muscular 67 
architectural damage, early inflammation, atrophy and fatty infiltration subsequent to 68 
combined tenotomy and neurectomy in an established PARP-1 knock-out mouse model 
19; 25
. 69 
The aim of this study was to investigate the role of PARP-1 in regulating the potentially 70 
irreversible structural alterations after RCT utilizing macroscopic, histological, molecular, and 71 
radiological techniques. 72 
73 




This investigation gained approval from the federal ethics committee (No. 98/2013). PARP-1 76 
knockout mice were originally obtained from Zhao-Qi Wang, PhD (Jena, Germany) and have 77 
been crossed back into the C57BL/6 background. These C57BL/6 mice have a PARP-1 gene 78 
fragment replaced by the neomycin resistance gene in between the second exon and intron 79 
(PARP-1 KO). The wild type (WT) C57BL/6JOlaHsd mice were obtained from Harlan 80 
Laboratories (Netherlands). The animals were housed in a specific pathogen free facility 81 
under standard enriched housing conditions. Only female mice between the ages of 6-8 weeks 82 
at the time of surgery were included in the study. 83 
Study design (Fig. 1) 84 
A total of 42 PARP-1 KO and 42 WT mice were included in the study. These mice underwent 85 
combined tenotomy and neurectomy of the supraspinatus (SSP) and infraspinatus (ISP) 86 
muscles. In both groups the animals were randomly assigned to three time points. The 1 week 87 
and 6 weeks time points included 12 animals each. These mice were then subdivided for 88 
either histological (Histology group) or gene expression (PCR group) analysis (n=6 each). 89 
The 12 weeks time point contained 18 animals in each of the PARP-1 KO and WT groups. 90 
These were then further subdivided for histological (Histology group), gene expression (PCR 91 
group) or MRI (MRI group) analysis (n=6 each).  92 
Surgery 93 
Tenotomy and denervation of the SSP and ISP was performed according to published 94 
protocols by Liu et al. 
25
 and Kim et al. 
19
. Surgery was carried out on the left shoulder and the 95 
contralateral shoulder served as an uninjured control. Anesthesia was induced with 96 
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intraperitoneal administration of Ketamine 30mg/kg BW and maintained with inhaled 97 
Isoflurane. Intraoperative pain was controlled with subcutaneous injections of Buprenorphine 98 
01.mg/kg BW when indicated. The surgical site underwent sterile preparation and draping 99 
with chlorhexidine. All procedures were performed under a surgical microscope using 100 
microsurgical instruments. A 2 cm long skin incision was made over the shoulder joint and 101 
the deltoid muscle split parallel to its fibers to expose the underlying rotator cuff insertion. 102 
The deltoid was retracted with a forceps and the tendons of the SSP and ISP sharply detached 103 
from the humeral head. The trapezius was then split along its fibers over the lateral scapular 104 
spine. The SSP muscle was bluntly elevated to reach the suprascapular notch. The 105 
suprascapular nerve was identified and a 2 mm segment was resected from a point where it 106 
enters the notch to a point beyond its division into supraspinatus and infraspinatus branches. 107 
The muscular split in the trapezius and deltoid muscles were then repaired with 10-0 Etibond 108 
sutures (Ethicon, USA). The skin incision was closed using staples. The animals were allowed 109 
free cage activity with food and water ad libidum post surgery. Postoperative pain was 110 
controlled with subcutaneous injections of Buprenorphine 01.mg/kg BW in the first day after 111 
surgery followed by Buprenorphine 1ml/50ml H2O in the drinking water for 3 days.  112 
Sacrifice and Sampling 113 
At the specified time points post intervention, the mice in the histology group were 114 
euthanized with cervical dislocation under anesthesia followed by harvest of the entire upper 115 
extremity of both shoulders with the rotator cuff muscles intact. These samples were 116 
immediately fixed in 4% Formalin. The animals in the PCR group underwent further 117 
Ketamine 30mg/kg BW induction and anesthesia with Isoflurane. The SSP and ISP muscles 118 
from both shoulders were carefully dissected and elevated from the scapula and immediately 119 
stored in RNAlater (Quiagen) at -20°C for further analysis. After the muscles were harvested 120 
these animals were euthanized with cervical dislocation whilst anaesthetized.  121 
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A pilot study with 6 WT mice showed severe retraction of the tendon stump in all 6 animals 122 
marked with non-absorbable sutures, macroscopic atrophy and fatty infiltration of the muscles 123 
12 weeks after surgery (data not shown). 124 
Histology 125 
For both immunohistochemistry (IHC) and conventional histological analysis the harvested 126 
SSP and ISP muscles were fixed in 4% Formalin overnight, washed with deionised water and 127 
stored in 70% Ethanol until parraffin embedding. Once embedded in paraffin, they were 128 
sectioned, deparaffinized, rehydrated in xylene and ethanol and then incubated with specific 129 
antibodies. For routine histology, H&E and Picrosirius Red staining was performed as per 130 
institutional standard operating procedure. The slides were digitalized with a NanoZoomer 131 
2.0-HT Digital slide scanner C9600 (Hamatsu, Japan) in various magnifications to allow 132 
further digital processing and analysis.  133 
 134 
To visualize intramuscular fat deposition, the midportions of SSP cross-sections were stained 135 
with a rabbit anti-mouse antibody against Fabp4 (HPA002188, Sigma-Aldrich, USA). Fatty 136 
infiltration, measured by the deposition of adipocytes between the muscle fiber bundles 137 
(perimysial) or within the muscle bundles due to replacement of muscle fibers (endomysial), 138 
was graded from 0 to 5 (0= no intramuscular fat except around the main vessel; 1= Single 139 
intramuscular fat cells or fat cells that penetrate from the vessel into the muscle; 2= Streaks of 140 
fat cells into the muscle; 3=Fatty streaks in 2 of 4 quadrants of the muscle; 4=fat cells in all 141 
quadrants; 5=severe fatty infiltration). This cell surface marker does not differentiate between 142 
the two localities. 143 
 144 
The pennation angle was measured three times at different locations and the mean of these 145 
measurements used for comparison in the longitudinal sections of the ISP muscle in the 146 
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Picrosirius Red stained sections at 20x magnification. The H&E sections underwent semi 147 
quantitative analysis. The cross section of the SSP muscle was divided into four quadrants 148 
and four images at 20x magnification were taken from each quadrant and analyzed for the 149 
frequency of inflammatory cell infiltrate, degenerative cells (hypereosinophilic staining, cell 150 
swelling, fragmentation, presence of retraction caps), regenerative cells (rows of myoblast 151 
nuclei,  cytoplasmic basophilia, internal nuclei), muscular atrophy (rounded to angular cells, 152 
hypereosinophilc sarcoplasm, crowded nuclei), fibrosis and fat deposition by a veterinary 153 
pathologist who was blinded to the sample group. 154 
Gene expression 155 
The entire SSP samples for Real Time qPCR (RTqPCR) were stored in RNAlater at -20°C 156 
until RNA extraction. The TrizolPlus Kit (Life Technologies) was utilized for RNA 157 
extraction. The samples were homogenized in 1ml Trizol per 100mg tissue using a MixerMill 158 
(Qiagen). After homogenization RNA was isolated by phase separation with 0.2ml 159 
chloroform and incubation. The upper phase, containing the RNA, was then transferred to a 160 
new tube and one volume 70% Ethanol was added. The solution was then transferred to the 161 
Spin Cartridges for binding and washing as per standard manufacturers protocol, which 162 
included DNase digestion. The purified RNA was then eluted in 30µl RNase free water. The 163 
relative amount of RNA was measured with a NanoDrop spectrophotometer (Thermo 164 
Scientific) and equal amounts of RNA were then reverse transcribed to cDNA with a RNA-to-165 
cDNA Kit (Life Technologies) as per standard manufacturer’s protocol. RTqPCR was 166 
performed on a 7500 Fast Real-Time PCR system (Applied Biosystems, USA) using TaqMan 167 
probes with Fast Advanced Mastermix for the expression of inflammatory (NF-κB, IL1-ß, 168 
TNFα, IL-6), apoptotic (Caspase3, AIF), atrophic (FOXOS1, MuRF, Atrogin1, Ube2b, 169 
Ube3a), regenerative (AKT, MyoD1, Myf-5), fibrotic (TGFß1 and MSTN) and fatty 170 
infiltration  (PPARγ, Fabp4) genes. GADPH serves as the housekeeping gene and relative 171 
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levels of gene expression are measured with the ∆∆Ct method relative to the contralateral 172 
uninjured side.  173 
MRI 174 
We acquired T1 weighted images using a RARE sequence (Rapid Acquisition with 175 
Relaxation Enhancement) for the anatomic depiction. For the fat quantification in-phase and 176 
out-of-phase sequences were performed 
33
. The sequences included the following scanning 177 
parameters: In-phase (flip angle: 50°; echo time: 2.9 ms; repetition time: 200 ms), Out-of-178 
phase (flip angle: 50°; echo time: 2.2 ms; repetition time 200 ms) and RARE T1 (flip angle: 179 
180°; echo_time: 10 ms; repetition time: 1000 ms). All data was acquired on a 4.7-T 180 
PharmaScan (Bruker Corporation, Billerica, MA, USA). A linear polarized hydrogen whole-181 
body mouse radiofrequency coil was used. The mice were laid head first and in prone position 182 
on an animal bed. We fitted the bed with a pad with continuous flow of warm water in order 183 
to avoid cooling of the animals. The animals were anesthetized during the acquisition with 184 
isoflurane (Attane, Minrad I, Buffalo, NY) and ophthalmic ointment (Vitamin A Crème, 185 
Bausch & Lomb, Steinhausen, Switzerland) was applied to protect the mice from dry eyes. 186 
With the acquired data a region of interest (ROI) analysis was done using in house Matlab 187 
routines (The MathWorks, Natick, MA) for the fat quantification. 188 
Statistics 189 
Statistical analysis included analysis of variance (ANOVA) and post Hoc tests to reveal 190 
differences between the subgroups with the Fisher’s LSD test or Mann-Whitney test for non-191 
parametric measurements. Linear correlation was measured with the Pearson product-moment 192 
correlation coefficient. The level of significance was set to p<0.05. Data is reported as the 193 
mean ± standard error of the mean (SEM).194 
PARP-1 Regulates Muscular Deterioration After RCT 
 10 
Results 195 
All animals survived the surgical procedure with no postoperative complications. All mice 196 
used their operated left forelimb less than the contralateral side, and the expected gait 197 
abnormality secondary to diminished use of the affected limb continued until euthanasia. 198 
There was no evidence of any adverse effects (e.g. developmental or reproductive 199 
abnormalities) on examination of the PARP-1 KO mice 
43
. 200 
Macroscopic Analysis 201 
All mice in both groups showed retraction of the tendon and muscle of the SSP and ISP at 1 202 
week, with further retraction evident at 6 weeks post combined tenotomy and neurectomy.  203 
The retraction and atrophy remained unchanged in the WT group at 12 weeks post surgery. 204 
In contrast, the PARP-1 KO mice had less retraction and almost normal muscle volume at the 205 
12 weeks time point. Sample images are shown in Fig. 2:A.  206 
 207 
Retraction was quantified on MRI scans (Fig. 2B and Fig. 2D) at the 12 week time point. 208 
Both tendon and muscle retraction was significantly lower in the PARP-1 KO mice compared 209 
to the WT mice (p = 0.012 and p = 0.081 respectively, Fig. 2D and Table 1). The correlation 210 
between muscle and tendon retraction reached statistical significance. (PARP-1 KO: r = 0.91, 211 
p = 0.001; WT: r = 0.98, p = 0.0001).  212 
 213 
The wet weight of the SSP muscle decreased significantly in both the PARP-1 KO and in the 214 
WT mice (relative decrease compared to uninjured contralateral side in Fig. 2C and effective 215 
weight in Table 1) in the first 6 weeks post combined tenotomy and neurectomy compared to 216 
the uninjured contralateral sideAt 12 weeks post surgery the wet weight of the SSP in PARP-217 
1 KO mice was almost normal in comparison to the contralateral side whilst it remained 218 
significantly lower in the WT mice (difference p < 0.0001, Fig. 2C and Table 1). 219 
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Histology  220 
In comparison to the uninjured contralateral side of all animals (Control: 23.9 ± 0.9°; Fig. 3E 221 
and Table 2) there was a statistically significant increase in pennation angle in the WT mice 222 
(1 week: 31.1 ± 2.4°; p = 0.016, 6 weeks: 36.1 ± 4.9°; p = 0.0002, 12 weeks: 34.4 ± 5.9°; p = 223 
0.0014 respectively). Conversely, after an initial increase in the pennation angle in the PARP-224 
1 KO mice it remained unchanged at the 6 and 12 weeks time points and did not reach 225 
statistical significance when compared to the controls (1 week: 30.0 ± 3.5°; p = 0.088, 6 226 
weeks: 28.1 ± 4.9°; p = 0.155, 12 weeks: 28.5 ± 3.9°; p = 0.103 respectively). There was a 227 
statistically significant correlation between the pennation angle, and the tendon and muscle 228 
retraction measurements in the PARP-1 KO mice (r = 0.93, p = 0.008 and r = 0.9, p = 0.014 229 
respectively) but not in the WT mice (r = -0.38, p = 0.517 and r = -0.36, p = 0.546 230 
respectively). 231 
 232 
H&E staining of the SSP cross sections showed a higher inflammatory cell infiltrate at 1 week 233 
post injury in the WT mice (Fig. 3A). This was followed by an increase in degenerative 234 
changes in both groups, with muscle fibers undergoing degradation and atrophy at 6 weeks. 235 
PARP-1 KO mice had a higher number of regenerating fibers at this time point. After 12 236 
weeks almost no degenerative changes were observed in either group. Muscles of the PARP-1 237 
KO group had less fibrosis and better muscle architecture compared to the WT group (Fig. 238 
3D).  239 
Fatty infiltration  240 
Both groups had no fatty infiltration at 1 week (data not shown). Fatty infiltration was present 241 
in both groups at 6 weeks with an average grade of 2.7 ± 0.49 in the PARP-1 KO mice and 242 
2.3 ± 0.49 in the WT mice (difference: p = 0.818 Fig. 3B and C). This almost significantly 243 
decreased in the PARP-1 KO mice to 1.4 ± 0.25 at 12 weeks post surgery (p = 0.082), which 244 
PARP-1 Regulates Muscular Deterioration After RCT 
 12 
was significantly lower than in the WT mice (2.8 ± 0.37; difference p = 0.032). Intramuscular 245 
fat was also quantified in the In-Phase and Opposed-Phase of the MR scans. The relative 246 
amount of intramuscular fat was significantly lower in the PARP-1 KO group (12.5 ± 1.82%) 247 
compared to the WT group (19.6 ± 1.96%; difference p = 0.027).  248 
Gene Expression Analysis 249 
Gene expression analysis of various inflammatory genes revealed that TNFα mRNA was 250 
upregulated at 1 and 12 weeks after injury in both PARP-1 KO and WT mice without 251 
reaching statistical significance (p = 0.775 and p = 0.390 respectively, Fig 4A). IL1-ß 252 
expression was upregulated at 1 and 6 weeks post surgery in the WT group without reaching 253 
statistical significance when compared to the PARP-1 KO mice (1 week: p = 0.197, 6 weeks: 254 
p = 0.110). There was a significant upregulation of NF-κB and the proapoptotic factor AIF at 255 
the 1-week time point in the WT group (p < 0.0001 and p = 0.005 respectively). The mRNA 256 
of the proliferative factors TGFß1 and MSTN were also significantly upregulated in the WT 257 
group at 1 week (p < 0.0001 and p = 0.0038 respectively, Fig. 4B). The muscle atrophy 258 
related Ubiquitin ligases MuRF1 and Atrogin-1 were present at significantly (p = 0.048 and p 259 
= 0.0018 respectively) higher levels in the WT group consistent with the higher levels of 260 
Ubiquitin ligase Ube3a mRNA at the 1-week time point (p < 0.0001, Fig. 4C). The mRNA 261 
level of regulatory protein FOXO1 was also significantly upregulated in the WT mice at 6 262 
weeks (p = 0.013, Fig. 4C). The main regulator of muscle regeneration AKT was equally 263 
upregulated in the PARP-1 KO and WT group at 1 and 12 weeks (p = 0.447 and p = 0.990 264 
respectively, Fig. 4D). Both MyoD and Myf-5 mRNA was upregulated at week 1 and week 6 265 
post surgery in both groups. The upregulation of both factors was significantly higher at week 266 
1 in the WT group compared to the PARP-1 KO group (p = 0.0053 and p = 0.012 267 
respectively, Fig. 4D). The mRNA levels of genes regulating fatty infiltration were 268 
significantly upregulated at 6 weeks in the WT group (PPARγ: p = 0.012 and Fabp4: p = 269 
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0.0124 Fig. 4E).  270 
PARP-1 Regulates Muscular Deterioration After RCT 
 14 
Discussion 271 
Disturbed muscular architecture, complete atrophy and fatty infiltration remain irreversible in 272 
chronic rotator cuff tears even after repair. The complex interplay of molecular and cellular 273 
mechanisms, which leads to potentially irreversible structural alterations in skeletal muscle 274 
have been described 
22
. Poly (ADP-ribose) polymerase-1 (PARP-1), also known as ADP-275 
ribosyl-transferase (ARTD1), is a key transcription factor involved in the maintenance of 276 
cellular homeostasis 
21
. PARP-1 has shown to be a key regulator of inflammation, apoptosis, 277 
muscle atrophy, muscle regeneration and adipocyte development 
7; 14; 40
. Our study is the first 278 
to show that the absence of PARP-1 leads to a reduction in muscular architectural damage in 279 
the mice’ supraspinatus and infraspinatus muscle. PARP-1 may be the upstream regulator that 280 
orchestrates the molecular and cellular mechanisms that leads to these potentially irreversible 281 
structural alterations after RCT. 282 
 283 
Macroscopic analysis showed different degrees of tendon and muscle retraction in both WT 284 
and PARP-1 KO mice at 1 and 6 weeks post combined tenotomy and neurectomy. After 12 285 
weeks retraction of the tendon and muscle was significantly lower in the PARP-1 KO mice 286 
compared to the WT mice measured in MRI scans. In a 2006 sheep study, Meyer et al. also 287 
showed that the tendon retracts more than muscle in experimental chronic tears of the rotator 288 
cuff. This results in an apparently shortened tendon 
31
. In our study, despite the degree of fatty 289 
infiltration being less than 50% of the muscle volume (< Goutallier stage 3) in all animals the 290 
degree of tendon retraction was consistently much greater than muscle retraction.  291 
 292 
Liu et al. observed significant and consistent muscle atrophy after rotator cuff tendon 293 
transection in a mouse model 
25
. Furthermore they found that denervation significantly 294 
increased the amount of muscle atrophy after a rotator cuff tear in a mouse model 
25
. Muscle 295 
atrophy persisted in the WT group in our study whilst the PARP-1 KO mice had almost 296 
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normal muscle volume at the 12 weeks time point. This occurrence was further supported by 297 
near normalization of the wet weight of the SSP in PARP-1 KO mice, whilst it remained low 298 
in the WT mice after the initial decrease in both groups. Only after continuous elongation and 299 
subsequent refixation do retracted, fatty infiltrated and atrophied rotator cuff muscles in 300 




Meyer et al. 
30
 described the pathomechanical concept of the pennation angle to explain 303 
muscle loss and fatty infiltration following RCT. Geometric modeling showed that the 304 
increase of the pennation angle separates the muscle fiber bundles mechanically like limbs of 305 
a parallelogram. Infiltrating fat cells fill the created space between the reoriented muscle 306 
fibers, which may be quantitatively calculated without affecting the structural properties of 307 
the muscle cells. Our histological data was consistent with the macroscopic findings. Both 308 
groups in our study demonstrated an increase in the pennation angle at 1 week following 309 
combined tenotomy and neurectomy. There was a further increase in the pennation angle in 310 
the WT mice at 6 weeks and it remained high at 12 weeks. Whilst in the PARP-1 KO mice the 311 
pennation angle remained unchanged at 6 and 12 weeks. In contrast to the WT group, the 312 
increase in pennation angle in the PARP-1 KO mice did not reach statistical significance 313 
when compared to the controls at any time point. 314 
 315 
Fatty infiltration was present in both groups at 6 weeks. The infiltration decreased in the 316 
PARP-1 KO mice to 1.4 ± 0.25 at 12 weeks post surgery, which was significantly lower than 317 
in the WT mice where the grading conversely increased to 2.8 ± 0.37 from the 6 week time 318 
point. The MRI measurement of relative intramuscular fat was also significantly lower in the 319 
PARP-1 KO group at 12 weeks. Gerber et al. demonstrated an arrest of fatty infiltration after 320 
continuous elongation and refixation in a sheep model 
10
. In a sheep study, neither an anabolic 321 
steroid nor IGF contributes to regeneration of the muscle once degenerative changes are 322 
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established. The findings demonstrated that muscle cells lose reactiveness to an anabolic 323 
steroid and IGF once retraction has led to fatty infiltration and atrophy of the muscle 
11
 324 
Treatment of mice with Tamoxifen , a competitive estrogen receptor inhibitor, has shown to 325 
cause less atrophy and inflammation after RCT but fatty infiltration remained unchanged 
4
. To 326 
date there is only one other study in the literature that has demonstrated reversal of fatty 327 
infiltration; through local administration of adipose-derived stem cells (ADSCs) into repaired 328 
rabbit SSC muscle, Oh et al. demonstrated improvement in fatty infiltration and tendon 329 
healing 
34
. As we have significantly less fatty infiltration and atrophy at 12 weeks in the 330 
PARP-1 KO group, one may speculate that outcome post fixation of the RCT in this group 331 
may have an improved surgical outcome. 332 
 333 
Results of the gene expression analysis further support the hypothesis that PARP-1 may be an 334 
instrumental upstream regulator that orchestrates potentially irreversible structural alterations 335 
after RCT. Regeneration and degeneration are in harmony during normal muscle homeostasis. 336 
RCT incite an inflammatory response that begins with inflammatory cell infiltration and 337 
subsequent release of proinflammatory cytokines 
32
. Intramuscular macrophages release 338 
TNF and IL1-ß and thereby stimulate the up-regulation of NF-κB. NF-κB has an integral 339 
role in influencing muscle degeneration 
23; 42
; (1) it co-regulates the expression of 340 
inflammatory and proapoptotic cytokines that cause muscle damage, (2) promotes muscular 341 
atrophy and degradation directly via activation of MuRF1 or indirectly via up-regulation of 342 
other cytokines and (3) it inhibits myogenic differentiation and regeneration. PARP-1 has 343 
been shown to be an important co-factor for NF-κB dependent transcription of various genes 344 
14
 and the disturbance of this interaction leads to a lower inflammatory reaction to injury 
14
. 345 
Studies have shown that inactivation or deletion of PARP-1 protects tissues from damage 346 
(review in Kraus and Hottiger, 2013) 
21
.  347 
 348 
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Our results show an inflammatory response at 1 week post combined tenotomy and 349 
neurectomy of the SSP and ISP muscles in the PARP-1 KO and the WT mice. TNF and IL-350 
1ß are extracellular inflammatory cytokines that induce intracellular inflammatory cascades. 351 
They were upregulated in both groups but only lead to a significant upregulation of NF-κB in 352 
the muscles of WT mice. This may be explained by a dampened inflammatory response and 353 
subsequent reduction in proinflammatory cytokine expression in the muscles of PARP-1 KO 354 
mice 
13
. Only the WT mice had significantly higher levels of the pro-apoptotic AIF, which is 355 
activated by PARP-1 and promotes caspase independent apoptosis. AIF translocates into the 356 
nucleus where it triggers apoptosis 
44
. The increase in pro-apoptotic gene expression suggests 357 
higher apoptosis rates in WT mice leading to a more pronounced cell death in this group. 358 
 359 
Unloading or denervation of the musculotendinous unit initiates complex pathways that 360 
eventually result in muscle ubiquitination and degradation 
41. Ubiquitination requires ligase’s 361 
to form complexes with Ube3a (Ubiquitin-protein ligase E3A) that allows recognition and 362 
proteosome mediated degradation of muscle fibers 
41
. The most important of these ligase’s are 363 
MuRF1 (muscle RING finger 1) and Atrogin-1 (FBX032) 
3
. Their transcription is upregulated 364 
by inflammatory, profibrotic, proadipogenic and the forkhead box 0 (FOX0) transcription 365 
factors 
23; 29; 36; 38
. The key elements involved in the process of ubiquitination and muscle 366 
degradation, Ube3a, MuRF1 and Atrogin-1, were all significantly upregulated in the WT mice 367 
at 1 week post combined tenotomy and neurectomy. 368 
 369 
During muscle regeneration satellite cells and mesenchymal stem cells (MSC) are activated 370 
and undergo proliferation and differentiation (Review in 
45
). This process is orchestrated by 371 
the myogenic regulatory factors (MRF), such as MyoD and Myf-5, which are activated 372 
through the AKT/mTOR pathway 
45
. Additionally it has been shown that NF-κB has a direct 373 
inhibitory effect on muscular regeneration by inhibiting the MRF’s, specifically MyoD 13. 374 
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This inhibition of myogenic differentiation and regeneration is also a major effect of NF-κB 375 
in muscle degeneration. We interpret the significant up regulation of MyoD in WT mice after 376 
1 week as a failed attempt of the muscle to induce regeneration through stimulation of 377 
satellite cells and MSCs. Meanwhile in the absence of PARP-1 in the knock-out group, NF-378 
κB is not effective in inhibiting MyoD and less muscle fibers were damaged during the initial 379 
inflammatory response. Upregulation of MyoD, like in the WT group, is not needed and low 380 
levels of MyoD may be sufficient for regeneration of the muscle fibers leading to a 381 
normalization of the muscle weight after 12 weeks. 382 
 383 
Both factors, TGFß1 and Myostatin, were significantly upregulated in the WT group at 1 384 
week. The inflammatory cell infiltrate triggers the release of TGFß1 and Myostatin from the 385 
fibroblasts in the ECM 
18; 24
. Both factors belong to the Transforming Growth factor 386 
superfamily 
20
. Members of this TGF superfamily have been shown to induce fibrosis and 387 
regulate muscle mass 
28
. Specificially Myostatin inhibits myogenic differentiation by 388 
downregulating the expression of MyoD and Myogenin 
39
. PARP-1 modulates TGF-ß1 389 
activity via negative and positive feedback mechanisms allowing fine-tuning of these 390 
pathways 
6; 26
. Our data suggests that the significant early activation of TGF-ß1 transcription in 391 
WT mice directs the balance towards fibrosis and degeneration.  392 
 393 
Our study showed fatty infiltration in both mice groups at 6 weeks but significantly less fatty 394 
infiltration in PARP-1 KO mice after 12 weeks. Both  proadipogenic factors (Peroxisome 395 
proliferator-activated receptor-γ = PPARγ and Fatty Acid Binding Protein = FABP4) revealed 396 
a significantly higher expression in the WT mice compared to PARP-1 KO group at 6 weeks 397 
post-injury.  These proadipogenic genes are key factors in fat accumulation in between free 398 
inter- and intramyofibrillar spaces and also decrease the expression of MRF 
16
. In addition 399 
Myostatin and TGFß reduce the expression of the proadipogenic factors 
12
. This may be the 400 
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reason why PPARγ is only upregulated at 6 weeks - after the inhibitory effect of Myostatin 401 
and TGFß has dissipated. Furthermore, absence of PARP-1 directly inhibits the function of 402 
PPARγ 7; 17 and is a crucial regulator of adipogenic differentiation 8.  403 
 404 
There are limitations in this study. It could be suggested the differences observed in our study 405 
were due to reinnervation. This is not plausible for three reasons. Firstly, a 2 mm length of the 406 
nerve was transected from the main branch at its entrance into the scapular notch extending 407 
beyond its branches to the SSP ad ISP in both the WT and PARP-1 KO mice. Secondly, if the 408 
nerves were to reinnervate by chance, then we would expect more outliers in our data - all of 409 
our data, including muscle weight measurements, demonstrate no outliers with a narrow 410 
standard deviation. Thirdly, why should the reinnervation phenomena be confined to the 411 
PARP-1 KO group only and not occur in the WT group? Another possible criticism could be 412 
that we analyzed gene expression and not effective protein levels and their activity. This does 413 
limit our ability fully interpret the molecular mechanisms at play. We surgically transected the 414 
tendons of the SSP and ISP from its origin at the humeral head. This may not accurately 415 
mimic degenerative RCT seen in the human population, but to our knowledge there are no 416 
degenerative RCT mouse models. There are other animal models of chronic rotator cuff tears, 417 
but this would not allow us to use the PARP-1 knockout model.  This study relays on gene 418 
expression analysis and does not investigate the exact interactions between PARP-1 and the 419 
described proteins on a molecular level. Further molecular biological methods would be 420 
needed to describe these mechanisms. The first time point of 1 week may be perceived as a bit 421 
delayed to assess inflammation, but we were still able to observe significant differences 422 
between the PARP-1-KO and WT mice in all the various modes of analyses.  423 
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Conclusion 424 
Our study is the first to show that the absence of PARP-1 leads to a reduction in muscular 425 
architectural damage, early inflammation, apoptosis, atrophy and fatty infiltration after 426 
combined tenotomy and neurectomy of the rotator cuff muscle. PARP-1 is one of the 427 
upstream regulators that orchestrates the molecular and cellular mechanisms that leads to 428 
potentially irreversible structural alterations after RCT. It plays an important role in 429 
modulating the muscles reaction to RCT by promoting the immediate inflammatory response. 430 
This inflammatory response leads to apoptosis and damage to the muscle fibers and initiates 431 
muscular degeneration and atrophy. Architectural changes and loss of myocytes hinders the 432 
muscles ability to regenerate and ultimately leads to fatty infiltration. In the absence of 433 
PARP-1, the initial inflammatory response is dampened leading to less myocyte degeneration. 434 
Although the macroscopic muscles reaction to injury is similar in the first 6 weeks, its ability 435 
to regenerate is much greater in the PARP-1 KO group leading to a near normalization of the 436 
muscle substance and muscle weight, less retraction, and less fatty infiltration after 12 weeks. 437 
We conclude that PARP1 is a molecular regulator of muscular deterioration after RCT.438 
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Figure legends: 582 
Fig. 1: Flow chart of the experimental design including the time points of surgery and 583 
sacrifice.  584 
Fig. 2: Results of the macroscopic and MRI measurements. A: Representative macroscopic 585 
images showing less retraction of the tendon in PARP-1 KO mice compared to WT mice. The 586 
arrow indicates the distance of the tendon stump to the humeral head. B:  Representative 587 
images of the radiological retraction measurements in the MR scans. The arrow indicates the 588 
distance of the tendon stump to the humeral head. C: Muscle weight measurement. The 589 
relative weight to the contralateral uninjured side of the PARP-1 KO and Wild Type mice is 590 
shown in the bar graph. D: Bar graphs of the retraction measurements.  Statistical significant 591 
differences are shown * p<0.05, ** p<0.01 and **** p<0.0001. 592 
Fig. 3: Representative histological slides and results of the fat quantification and pennation 593 
angle measurement. A: Representative histological cross sections of the SSP stained with 594 
H&E after 1, 6 and 12 weeks. B: Representative histological cross sections stained with an 595 
antibody against Fabp4. C:  Fat quantification in the SSP muscles. Relative fat quantification 596 
in the MR scans with a 2-Point Dixon Method on a 4.7T small animal MRI scanner and 597 
histological grading of the endo- and perimysial fat content in the cross sections oft he SSP 598 
muscles stained with Fabp4.  D: Representative histological cross sections of the SSP stained 599 
with Picrosirius Red to visualize the connective tissue. E: Pennation angle measurements in 600 
the Picrosirius Red stained longitudinal sections of the ISP muscles of PARP-1 KO and WT 601 
mice and bar graphs indicating the degree of the angle. The contralateral side of both groups 602 
acted as an uninjured control measurement.  Statistical significant differences are shown * 603 
p<0.05, ** p<0.01 and *** p<0.001. 604 
Fig. 4: Results of the gene expression analysis with real time RT-PCR. The increase of 605 
mRNA levels is shown as fold expression compared to the uninjured contralateral side with 606 
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the ΔCt method. A: Genes of the inflammatory cascade  (TNF, IL-1ß and NF-κB) and 607 
apoptosis (AIF). B: Proliferative factors of the TGFß superfamily represented by TGFß1 and 608 
Myostatin. C: Genes involved in the degeneration of muscle fibers. Foxo1 is the upstream 609 
regulator of the Ubiquitin-Ligases MuRF1 and Atrogin-1, which bind to Ube3a. D: Genes for 610 
muscular regeneration. AKT is the upstream regulator of the MRFs here represented by 611 
MyoD1 and Myf-5. E: Genes regulating fatty infiltration (PPARγ) and binding of fatty acids 612 
(Fabp4). Statistical significant differences are shown * p<0.05, ** p<0.01 and **** p<0.0001. 613 
Fig. S 1: Supplemental results of the gene expression analysis with real time RT-PCR. The 614 
increase of mRNA levels is shown as fold expression compared to the uninjured contralateral 615 
side with the ΔCt method. A: Genes of the inflammatory cascade (IL6) and apoptosis 616 
(Casp3). B: Proliferative factors TGFß3. C: Genes involved in the degeneration of muscle 617 
fibers Foxo3 and Ube2b. D: Gene for muscular regeneration, Myogenins. E: Genes regulating 618 
fatty infiltration Leptin. Statistical significant differences are shown with * p<0.05 and **** 619 
p<0.0001. 620 
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